APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lancets

Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications.

These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.

Selected research

Market Outlook & Growth Opportunities

Global Lancets Market Outlook and Growth Opportunities 2026

1 January 2026210 pages

Choose your research edition.

Industry ResearchLancets Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Lancets Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Lancets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lancets Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Lancets Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications.

These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.

The major players in global Lancets market include Roche, Lifescan, BD, etc. The top 3 players occupy about 30% shares of the global market. Europe and North America are main markets, they occupy about 70% of the global market. Homecare Lancets is the main type, with a share about 80%. Glucose Tests is the main application, which holds a share about 70%.

Read the full market overview

This report provides an overview of the global Lancets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lancets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lancets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lancets market size, projected growth trends, production technologies, key applications, and end-use industries.

Lancets Segment by Company

Roche

Lifescan

BD

Bayer

Abbott

B. Braun

ARKRAY

Terumo

I-SENS

Nipro

Omron

Infopia

AgaMatrix

Smiths Medical

Sarstedt

SANNUO

Yicheng

Yuwell

Greiner Bio One

Edan

Narang Medical

Lancets Segment by Type

Safety Lancets

Homecare Lancets

Lancets Segment by Application

Cholesterol Tests

Glucose Tests

Others

Lancets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Lancets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Lancets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Lancets significant trends, drivers, influence factors in global and regions.

6. To analyze Lancets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lancets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lancets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lancets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lancets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lancets industry.

Chapter 3: Detailed analysis of Lancets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Lancets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Lancets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Lancets Industry Trends Table 2. Lancets Industry Drivers Table 3. Lancets Industry Opportunities and Challenges Table 4. Lancets Industry Restraints Table 5. Global Lancets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Lancets Revenue Share by Company (2021-2026) Table 7. Global Lancets Sales Volume by Company (M Units) & (2021-2026) Table 8. Global Lancets Sales Volume Share by Company (2021-2026) Table 9. Global Lancets Average Price (US$/K Units) of Company (2021-2026) Table 10. Global Lancets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Lancets Key Company Manufacturing Base & Headquarters Table 12. Global Lancets Company, Product Type & Application Table 13. Global Lancets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Lancets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Safety Lancets Table 18. Significant Companies of Homecare Lancets Table 19. Global Lancets Sales Volume by Type 2021 VS 2025 VS 2032 (M Units) Table 20. Global Lancets Sales Volume by Type (2021-2026) & (M Units) Table 21. Global Lancets Sales Volume by Type (2027-2032) & (M Units) Table 22. Global Lancets Sales Volume Share by Type (2021-2026) Table 23. Global Lancets Sales Volume Share by Type (2027-2032) Table 24. Global Lancets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Lancets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Lancets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Lancets Sales Value Share by Type (2021-2026) Table 28. Global Lancets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Cholesterol Tests Table 30. Significant Companies of Glucose Tests Table 31. Significant Companies of Others Table 32. Global Lancets Sales Volume by Application 2021 VS 2025 VS 2032 (M Units) Table 33. Global Lancets Sales Volume by Application (2021-2026) & (M Units) Table 34. Global Lancets Sales Volume by Application (2027-2032) & (M Units) Table 35. Global Lancets Sales Volume Share by Application (2021-2026) Table 36. Global Lancets Sales Volume Share by Application (2027-2032) Table 37. Global Lancets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Lancets Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Lancets Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Lancets Sales Value Share by Application (2021-2026) Table 41. Global Lancets Sales Value Share by Application (2027-2032) Table 42. Global Lancets Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 43. Global Lancets Sales by Region (2021-2026) & (M Units) Table 44. Global Lancets Sales Market Share by Region (2021-2026) Table 45. Global Lancets Sales by Region (2027-2032) & (M Units) Table 46. Global Lancets Sales Market Share by Region (2027-2032) Table 47. Global Lancets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Lancets Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Lancets Sales Value Share by Region (2021-2026) Table 50. Global Lancets Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Lancets Sales Value Share by Region (2027-2032) Table 52. Global Lancets Market Average Price (US$/K Units) by Region (2021-2026) Table 53. Global Lancets Market Average Price (US$/K Units) by Region (2027-2032) Table 54. Global Lancets Sales by Country: 2021 VS 2025 VS 2032 (M Units) Table 55. Global Lancets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Lancets Sales by Country (2021-2026) & (M Units) Table 57. Global Lancets Sales Market Share by Country (2021-2026) Table 58. Global Lancets Sales by Country (2027-2032) & (M Units) Table 59. Global Lancets Sales Market Share by Country (2027-2032) Table 60. Global Lancets Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Lancets Sales Value Market Share by Country (2021-2026) Table 62. Global Lancets Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Lancets Sales Value Market Share by Country (2027-2032) Table 64. Roche Company Information Table 65. Roche Business Overview Table 66. Roche Lancets Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 67. Roche Lancets Product Portfolio Table 68. Roche Recent Development Table 69. Lifescan Company Information Table 70. Lifescan Business Overview Table 71. Lifescan Lancets Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 72. Lifescan Lancets Product Portfolio Table 73. Lifescan Recent Development Table 74. BD Company Information Table 75. BD Business Overview Table 76. BD Lancets Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 77. BD Lancets Product Portfolio Table 78. BD Recent Development Table 79. Bayer Company Information Table 80. Bayer Business Overview Table 81. Bayer Lancets Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 82. Bayer Lancets Product Portfolio Table 83. Bayer Recent Development Table 84. Abbott Company Information Table 85. Abbott Business Overview Table 86. Abbott Lancets Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 87. Abbott Lancets Product Portfolio Table 88. Abbott Recent Development Table 89. B. Braun Company Information Table 90. B. Braun Business Overview Table 91. B. Braun Lancets Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 92. B. Braun Lancets Product Portfolio Table 93. B. Braun Recent Development Table 94. ARKRAY Company Information Table 95. ARKRAY Business Overview Table 96. ARKRAY Lancets Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 97. ARKRAY Lancets Product Portfolio Table 98. ARKRAY Recent Development Table 99. Terumo Company Information Table 100. Terumo Business Overview Table 101. Terumo Lancets Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 102. Terumo Lancets Product Portfolio Table 103. Terumo Recent Development Table 104. I-SENS Company Information Table 105. I-SENS Business Overview Table 106. I-SENS Lancets Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 107. I-SENS Lancets Product Portfolio Table 108. I-SENS Recent Development Table 109. Nipro Company Information Table 110. Nipro Business Overview Table 111. Nipro Lancets Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 112. Nipro Lancets Product Portfolio Table 113. Nipro Recent Development Table 114. Omron Company Information Table 115. Omron Business Overview Table 116. Omron Lancets Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 117. Omron Lancets Product Portfolio Table 118. Omron Recent Development Table 119. Infopia Company Information Table 120. Infopia Business Overview Table 121. Infopia Lancets Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 122. Infopia Lancets Product Portfolio Table 123. Infopia Recent Development Table 124. AgaMatrix Company Information Table 125. AgaMatrix Business Overview Table 126. AgaMatrix Lancets Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 127. AgaMatrix Lancets Product Portfolio Table 128. AgaMatrix Recent Development Table 129. Smiths Medical Company Information Table 130. Smiths Medical Business Overview Table 131. Smiths Medical Lancets Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 132. Smiths Medical Lancets Product Portfolio Table 133. Smiths Medical Recent Development Table 134. Sarstedt Company Information Table 135. Sarstedt Business Overview Table 136. Sarstedt Lancets Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 137. Sarstedt Lancets Product Portfolio Table 138. Sarstedt Recent Development Table 139. SANNUO Company Information Table 140. SANNUO Business Overview Table 141. SANNUO Lancets Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 142. SANNUO Lancets Product Portfolio Table 143. SANNUO Recent Development Table 144. Yicheng Company Information Table 145. Yicheng Business Overview Table 146. Yicheng Lancets Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 147. Yicheng Lancets Product Portfolio Table 148. Yicheng Recent Development Table 149. Yuwell Company Information Table 150. Yuwell Business Overview Table 151. Yuwell Lancets Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 152. Yuwell Lancets Product Portfolio Table 153. Yuwell Recent Development Table 154. Greiner Bio One Company Information Table 155. Greiner Bio One Business Overview Table 156. Greiner Bio One Lancets Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 157. Greiner Bio One Lancets Product Portfolio Table 158. Greiner Bio One Recent Development Table 159. Edan Company Information Table 160. Edan Business Overview Table 161. Edan Lancets Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 162. Edan Lancets Product Portfolio Table 163. Edan Recent Development Table 164. Narang Medical Company Information Table 165. Narang Medical Business Overview Table 166. Narang Medical Lancets Sales (M Units), Value (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026) Table 167. Narang Medical Lancets Product Portfolio Table 168. Narang Medical Recent Development Table 169. Key Raw Materials Table 170. Raw Materials Key Suppliers Table 171. Lancets Distributors List Table 172. Lancets Customers List Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Lancets Product Image Figure 2. Global Lancets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lancets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Lancets Sales (2021-2032) & (M Units) Figure 5. Global Lancets Sales Average Price (US$/K Units) & (2021-2032) Figure 6. Global Lancets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Safety Lancets Image Figure 10. Homecare Lancets Image Figure 11. Global Lancets Sales Volume by Type (2021 VS 2025 VS 2032) & (M Units) Figure 12. Global Lancets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Lancets Sales Volume Share by Type (2021-2032) Figure 14. Global Lancets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Lancets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Lancets Sales Value Share by Type (2021-2032) Figure 17. Cholesterol Tests Image Figure 18. Glucose Tests Image Figure 19. Others Image Figure 20. Global Lancets Sales Volume by Application (2021 VS 2025 VS 2032) & (M Units) Figure 21. Global Lancets Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Lancets Sales Volume Share by Application (2021-2032) Figure 23. Global Lancets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Lancets Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Lancets Sales Value Share by Application (2021-2032) Figure 26. Global Lancets Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 27. Global Lancets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Lancets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Lancets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Lancets Sales Value (2021-2032) & (US$ Million) Figure 31. North America Lancets Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Lancets Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Lancets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Lancets Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Lancets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Lancets Sales Value (2021-2032) & (US$ Million) Figure 37. South America Lancets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Lancets Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Lancets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Lancets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Lancets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Lancets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Lancets Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Lancets Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Safety Lancets
  • Homecare Lancets
Applications
  • Cholesterol Tests
  • Glucose Tests
  • Others
Companies covered
  • Roche
  • Lifescan
  • BD
  • Bayer
  • Abbott
  • B. Braun
  • ARKRAY
  • Terumo
  • I-SENS
  • Nipro
  • Omron
  • Infopia
  • AgaMatrix
  • Smiths Medical
  • Sarstedt
  • SANNUO
  • Yicheng
  • Yuwell
  • Greiner Bio One
  • Edan
  • Narang Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lancets Sales Value (2021-2032)
  4. 1.2.2 Global Lancets Sales Volume (2021-2032)
  5. 1.2.3 Global Lancets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Lancets Market Dynamics
  1. 2.1 Lancets Industry Trends
  2. 2.2 Lancets Industry Drivers
  3. 2.3 Lancets Industry Opportunities and Challenges
  4. 2.4 Lancets Industry Restraints
3 Lancets Market by Company
  1. 3.1 Global Lancets Company Revenue Ranking in 2025
  2. 3.2 Global Lancets Revenue by Company (2021-2026)
  3. 3.3 Global Lancets Sales Volume by Company (2021-2026)
  4. 3.4 Global Lancets Average Price by Company (2021-2026)
  5. 3.5 Global Lancets Company Ranking (2024-2026)
  6. 3.6 Global Lancets Company Manufacturing Base and Headquarters
  7. 3.7 Global Lancets Company Product Type and Application
  8. 3.8 Global Lancets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Lancets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Lancets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Lancets Market by Type
  1. 4.1 Lancets Type Introduction
  2. 4.1.1 Safety Lancets
  3. 4.1.2 Homecare Lancets
  4. 4.2 Global Lancets Sales Volume by Type
  5. 4.2.1 Global Lancets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Lancets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Lancets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Lancets Sales Value by Type
  9. 4.3.1 Global Lancets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Lancets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Lancets Sales Value Share by Type (2021-2032)
5 Lancets Market by Application
  1. 5.1 Lancets Application Introduction
  2. 5.1.1 Cholesterol Tests
  3. 5.1.2 Glucose Tests
  4. 5.1.3 Others
  5. 5.2 Global Lancets Sales Volume by Application
  6. 5.2.1 Global Lancets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lancets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Lancets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Lancets Sales Value by Application
  10. 5.3.1 Global Lancets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Lancets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Lancets Sales Value Share by Application (2021-2032)
6 Lancets Regional Sales and Value Analysis
  1. 6.1 Global Lancets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lancets Sales by Region (2021-2032)
  3. 6.2.1 Global Lancets Sales by Region: 2021-2026
  4. 6.2.2 Global Lancets Sales by Region (2027-2032)
  5. 6.3 Global Lancets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Lancets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Lancets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Lancets Sales Value by Region (2027-2032)
  9. 6.5 Global Lancets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Lancets Sales Value (2021-2032)
  12. 6.6.2 North America Lancets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Lancets Sales Value (2021-2032)
  15. 6.7.2 Europe Lancets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Lancets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Lancets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Lancets Sales Value (2021-2032)
  21. 6.9.2 South America Lancets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Lancets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Lancets Sales Value Share by Country, 2025 VS 2032
7 Lancets Country-level Sales and Value Analysis
  1. 7.1 Global Lancets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Lancets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Lancets Sales by Country (2021-2032)
  4. 7.3.1 Global Lancets Sales by Country (2021-2026)
  5. 7.3.2 Global Lancets Sales by Country (2027-2032)
  6. 7.4 Global Lancets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Lancets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Lancets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Lancets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Lancets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Lancets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Lancets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Lancets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Lancets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Lancets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Lancets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Lancets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Lancets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Lancets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Lancets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Lancets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Lancets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Lancets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Lancets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Lancets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Lancets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Lancets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Lancets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Lancets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Lancets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Lancets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Lancets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Lancets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Lancets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Lancets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Lancets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Lancets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Lancets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Lancets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Lancets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Lancets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Lancets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Lancets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Lancets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Lancets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Lancets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Lancets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Lancets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Lancets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Lancets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Lancets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Lancets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Lancets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Lancets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Lancets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Lancets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Lancets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Lancets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Lancets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Lancets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Lancets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Lancets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Lancets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Lancets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Lancets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Lancets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Lancets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Lancets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Lancets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Lancets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Lancets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Lancets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Lancets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Lancets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Lancets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Lancets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Lancets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Lancets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Lancets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Lancets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Lancets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Lancets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Lancets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Lancets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Lancets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Lancets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Lancets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Lancets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Lancets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Lancets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Lancets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Lancets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Roche
  2. 8.1.1 Roche Company Information
  3. 8.1.2 Roche Business Overview
  4. 8.1.3 Roche Lancets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Roche Lancets Product Portfolio
  6. 8.1.5 Roche Recent Developments
  7. 8.2 Lifescan
  8. 8.2.1 Lifescan Company Information
  9. 8.2.2 Lifescan Business Overview
  10. 8.2.3 Lifescan Lancets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Lifescan Lancets Product Portfolio
  12. 8.2.5 Lifescan Recent Developments
  13. 8.3 BD
  14. 8.3.1 BD Company Information
  15. 8.3.2 BD Business Overview
  16. 8.3.3 BD Lancets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 BD Lancets Product Portfolio
  18. 8.3.5 BD Recent Developments
  19. 8.4 Bayer
  20. 8.4.1 Bayer Company Information
  21. 8.4.2 Bayer Business Overview
  22. 8.4.3 Bayer Lancets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Bayer Lancets Product Portfolio
  24. 8.4.5 Bayer Recent Developments
  25. 8.5 Abbott
  26. 8.5.1 Abbott Company Information
  27. 8.5.2 Abbott Business Overview
  28. 8.5.3 Abbott Lancets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Abbott Lancets Product Portfolio
  30. 8.5.5 Abbott Recent Developments
  31. 8.6 B. Braun
  32. 8.6.1 B. Braun Company Information
  33. 8.6.2 B. Braun Business Overview
  34. 8.6.3 B. Braun Lancets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 B. Braun Lancets Product Portfolio
  36. 8.6.5 B. Braun Recent Developments
  37. 8.7 ARKRAY
  38. 8.7.1 ARKRAY Company Information
  39. 8.7.2 ARKRAY Business Overview
  40. 8.7.3 ARKRAY Lancets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 ARKRAY Lancets Product Portfolio
  42. 8.7.5 ARKRAY Recent Developments
  43. 8.8 Terumo
  44. 8.8.1 Terumo Company Information
  45. 8.8.2 Terumo Business Overview
  46. 8.8.3 Terumo Lancets Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Terumo Lancets Product Portfolio
  48. 8.8.5 Terumo Recent Developments
  49. 8.9 I-SENS
  50. 8.9.1 I-SENS Company Information
  51. 8.9.2 I-SENS Business Overview
  52. 8.9.3 I-SENS Lancets Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 I-SENS Lancets Product Portfolio
  54. 8.9.5 I-SENS Recent Developments
  55. 8.10 Nipro
  56. 8.10.1 Nipro Company Information
  57. 8.10.2 Nipro Business Overview
  58. 8.10.3 Nipro Lancets Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Nipro Lancets Product Portfolio
  60. 8.10.5 Nipro Recent Developments
  61. 8.11 Omron
  62. 8.11.1 Omron Company Information
  63. 8.11.2 Omron Business Overview
  64. 8.11.3 Omron Lancets Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Omron Lancets Product Portfolio
  66. 8.11.5 Omron Recent Developments
  67. 8.12 Infopia
  68. 8.12.1 Infopia Company Information
  69. 8.12.2 Infopia Business Overview
  70. 8.12.3 Infopia Lancets Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Infopia Lancets Product Portfolio
  72. 8.12.5 Infopia Recent Developments
  73. 8.13 AgaMatrix
  74. 8.13.1 AgaMatrix Company Information
  75. 8.13.2 AgaMatrix Business Overview
  76. 8.13.3 AgaMatrix Lancets Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 AgaMatrix Lancets Product Portfolio
  78. 8.13.5 AgaMatrix Recent Developments
  79. 8.14 Smiths Medical
  80. 8.14.1 Smiths Medical Company Information
  81. 8.14.2 Smiths Medical Business Overview
  82. 8.14.3 Smiths Medical Lancets Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Smiths Medical Lancets Product Portfolio
  84. 8.14.5 Smiths Medical Recent Developments
  85. 8.15 Sarstedt
  86. 8.15.1 Sarstedt Company Information
  87. 8.15.2 Sarstedt Business Overview
  88. 8.15.3 Sarstedt Lancets Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Sarstedt Lancets Product Portfolio
  90. 8.15.5 Sarstedt Recent Developments
  91. 8.16 SANNUO
  92. 8.16.1 SANNUO Company Information
  93. 8.16.2 SANNUO Business Overview
  94. 8.16.3 SANNUO Lancets Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 SANNUO Lancets Product Portfolio
  96. 8.16.5 SANNUO Recent Developments
  97. 8.17 Yicheng
  98. 8.17.1 Yicheng Company Information
  99. 8.17.2 Yicheng Business Overview
  100. 8.17.3 Yicheng Lancets Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Yicheng Lancets Product Portfolio
  102. 8.17.5 Yicheng Recent Developments
  103. 8.18 Yuwell
  104. 8.18.1 Yuwell Company Information
  105. 8.18.2 Yuwell Business Overview
  106. 8.18.3 Yuwell Lancets Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Yuwell Lancets Product Portfolio
  108. 8.18.5 Yuwell Recent Developments
  109. 8.19 Greiner Bio One
  110. 8.19.1 Greiner Bio One Company Information
  111. 8.19.2 Greiner Bio One Business Overview
  112. 8.19.3 Greiner Bio One Lancets Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Greiner Bio One Lancets Product Portfolio
  114. 8.19.5 Greiner Bio One Recent Developments
  115. 8.20 Edan
  116. 8.20.1 Edan Company Information
  117. 8.20.2 Edan Business Overview
  118. 8.20.3 Edan Lancets Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Edan Lancets Product Portfolio
  120. 8.20.5 Edan Recent Developments
  121. 8.21 Narang Medical
  122. 8.21.1 Narang Medical Company Information
  123. 8.21.2 Narang Medical Business Overview
  124. 8.21.3 Narang Medical Lancets Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Narang Medical Lancets Product Portfolio
  126. 8.21.5 Narang Medical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Lancets Value Chain Analysis
  2. 9.1.1 Lancets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Lancets Sales Mode & Process
  6. 9.2 Lancets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Lancets Distributors
  9. 9.2.3 Lancets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst